Renal disease company Tricida raises $57.5M

Tricida Inc. (South San Francisco, Calif.) raised $57.5 million in an oversubscribed series D round. The round included new investors Wellington Management Co., Venrock and Cormorant Asset Management. Existing investors OrbiMed Advisors, Longitude Capital, Sibling Capital Ventures, Limulus Venture Partners and Vivo Capital also participated...